All Stories

  1. Modification of a salmonid alphavirus replicon vector for enhanced expression of heterologous antigens

    Article • Journal of General Virology, November 2014, Society for General Microbiology

    Professor Peter Liljeström

  2. Self-replicating alphavirus RNA vaccines

    Article • Expert Review of Vaccines, October 2014, Taylor & Francis

    Professor Peter Liljeström

  3. Prime-Boost Immunization Strategies against Chikungunya Virus

    Article • Journal of Virology, September 2014, ASM Journals

    Professor Peter Liljeström

  4. Kinetic and Phenotypic Analysis of CD8+ T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations

    Article • Journal of Virology, August 2014, ASM Journals

    Professor Peter Liljeström

  5. A 6K-Deletion Variant of Salmonid Alphavirus Is Non-Viable but Can Be Rescued through RNA Recombination

    Article • PLoS ONE, July 2014, PLOS

    Professor Peter Liljeström

  6. A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection

    Article • Journal of Virology, January 2014, ASM Journals

    Professor Peter Liljeström

  7. Intradermal Electroporation of RNA

    Article • January 2014, Springer Science + Business Media

    Professor Peter Liljeström

  8. Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice

    Article • Journal of Virology, December 2013, ASM Journals

    Professor Peter Liljeström

  9. Virus replicon particle based Chikungunya virus neutralization assay using Gaussia luciferase as readout

    Article • Virology Journal, July 2013, Springer Science + Business Media

    Professor Peter Liljeström, Professor Marc Lecuit

  10. The Adjuvant Activity of Alphavirus Replicons Is Enhanced by Incorporating the Microbial Molecule Flagellin into the Replicon

    Article • PLoS ONE, June 2013, PLOS

    Professor Peter Liljeström, Dr Jean-Claude SIRARD

  11. Optimizing delivery of HIV-1 conserved region-derived immunogen for induction of T and B cell responses in rhesus macaques

    Article • Retrovirology, September 2012, Springer Science + Business Media

    Professor Peter Liljeström

  12. Host Gene Expression Signatures Discriminate between Ferrets Infected with Genetically Similar H1N1 Strains

    Article • PLoS ONE, July 2012, PLOS

    Professor Peter Liljeström

  13. De-Novo Transcriptome Sequencing of a Normalized cDNA Pool from Influenza Infected Ferrets

    Article • PLoS ONE, May 2012, PLOS

    Professor Peter Liljeström

  14. Differential Impact of Interferon Regulatory Factor 7 in Initiation of the Type I Interferon Response in the Lymphocytic Choriomeningitis Virus-Infected Central Nervous System versus the Periphery

    Article • Journal of Virology, April 2012, ASM Journals

    Professor Peter Liljeström, Allan R Thomsen

  15. Superior Induction of T Cell Responses to Conserved HIV-1 Regions by Electroporated Alphavirus Replicon DNA Compared to That with Conventional Plasmid DNA Vaccine

    Article • Journal of Virology, February 2012, ASM Journals

    Professor Peter Liljeström, Prof Arturo Reyes-Sandoval

  16. Intradermal Electroporation of Naked Replicon RNA Elicits Strong Immune Responses

    Article • PLoS ONE, January 2012, PLOS

    Professor Peter Liljeström

  17. Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1-uninfected volunteers: A phase I clinical trial (RISVAC02)

    Article • Vaccine, October 2011, Elsevier

    Professor Peter Liljeström

  18. Protective Efficacy of Serially Up-Ranked Subdominant CD8+ T Cell Epitopes against Virus Challenges

    Article • PLoS Pathogens, May 2011, PLOS

    Professor Peter Liljeström

  19. Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines

    Article • Virology Journal, January 2011, Springer Science + Business Media

    Professor Peter Liljeström, Associate Professor Margaret Chen

  20. Long peptides induce polyfunctional T cells against conserved regions of HIV‐1 with superior breadth to single‐gene vaccines in macaques

    Article • European Journal of Immunology, June 2010, Wiley

    Professor Peter Liljeström

  21. Preclinical Evaluation of the Immunogenicity of C-Type HIV-1-Based DNA and NYVAC Vaccines in the Balb/C Mouse Model

    Article • Viral Immunology, October 2009, Mary Ann Liebert Inc

    Professor Peter Liljeström

  22. P17-05. Dealing with HIV-1 diversity

    Article • Retrovirology, October 2009, Springer Science + Business Media

    Professor Peter Liljeström

  23. Comparison of Human and Rhesus Macaque T-Cell Responses Elicited by Boosting with NYVAC Encoding Human Immunodeficiency Virus Type 1 Clade C Immunogens

    Article • Journal of Virology, March 2009, ASM Journals

    Professor Peter Liljeström, Professor Jonathan Luke Heeney

  24. EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium

    Article • Vaccine, June 2008, Elsevier

    Professor Peter Liljeström, Professor Jonathan Luke Heeney

  25. An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses

    Article • The Journal of Experimental Medicine, January 2008, Rockefeller University Press

    Professor Peter Liljeström, Professor Jonathan Luke Heeney

  26. Increased human immunodeficiency virus type 1 Env expression and antibody induction using an enhanced alphavirus vector

    Article • Journal of General Virology, October 2007, Society for General Microbiology

    Professor Peter Liljeström

  27. Semliki Forest Virus Nonstructural Protein 2 Is Involved in Suppression of the Type I Interferon Response

    Article • Journal of Virology, June 2007, ASM Journals

    Professor Peter Liljeström

  28. Comparative Prime-Boost Vaccinations Using Semliki Forest Virus, Adenovirus, and ALVAC Vectors Demonstrate Differences in the Generation of a Protective Central Memory CTL Response against the P815 Tumor

    Article • The Journal of Immunology, May 2007, The American Association of Immunologists

    Professor Peter Liljeström

  29. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B

    Article • Vaccine, April 2007, Elsevier

    Professor Peter Liljeström

  30. Viral vectors for malaria vaccine development

    Article • Vaccine, March 2007, Elsevier

    Dr Thomas P. Monath, Professor Peter Liljeström

  31. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

    Article • Vaccine, March 2007, Elsevier

    Professor Peter Liljeström

  32. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates

    Article • Science, November 2006, American Association for the Advancement of Science

    Professor Peter Liljeström, Friedemann Weber

  33. Humoral Responses against Coimmunized Protein Antigen but Not against Alphavirus-Encoded Antigens Require Alpha/Beta Interferon Signaling

    Article • Journal of Virology, July 2006, ASM Journals

    Professor Peter Liljeström

  34. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles

    Article • Virology, October 2005, Elsevier

    Dr Gerald McInerney, Professor Peter Liljeström

  35. Modulation of Vaccine‐Induced Immune Responses to Hepatitis C Virus in Rhesus Macaques by Altering Priming before Adenovirus Boosting

    Article • The Journal of Infectious Diseases, September 2005, Oxford University Press (OUP)

    Professor Peter Liljeström, Professor Jonathan Luke Heeney

  36. Biochemical and Immunogenic Characterization of Soluble Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Trimers Expressed by Semliki Forest Virus

    Article • Journal of Virology, September 2005, ASM Journals

    Professor Peter Liljeström

  37. Early Alpha/Beta Interferon Production by Myeloid Dendritic Cells in Response to UV-Inactivated Virus Requires Viral Entry and Interferon Regulatory Factor 3 but Not MyD88

    Article • Journal of Virology, August 2005, ASM Journals

    Professor Peter Liljeström

  38. Reversible Acid-Induced Inactivation of the Membrane Fusion Protein of Semliki Forest Virus

    Article • Journal of Virology, June 2005, ASM Journals

    Professor Peter Liljeström

  39. MyD88 Expression Is Required for Efficient Cross-Presentation of Viral Antigens from Infected Cells

    Article • Journal of Virology, March 2005, ASM Journals

    Professor Peter Liljeström, Associate Professor Margaret Chen

  40. Toll-like receptor 3 promotes cross-priming to virus-infected cells

    Article • February 2005

    Professor Peter Liljeström

  41. T‐cell‐mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge

    Article • Journal of Medical Primatology, September 2004, Wiley

    Professor Peter Liljeström, Professor Jonathan Luke Heeney

  42. DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model

    Article • Vaccine, September 2004, Elsevier

    Professor Peter Liljeström

  43. Semliki Forest virus produced in the absence of the 6K protein has an altered spike structure as revealed by decreased membrane fusion capacity

    Article • Virology, August 2004, Elsevier

    Dr Gerald McInerney, Professor Peter Liljeström

  44. Immunization with PfEMP1-DBL1α generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes

    Article • Vaccine, July 2004, Elsevier

    Professor Peter Liljeström

  45. Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene

    Article • Gene Therapy, March 2004, Springer Science + Business Media

    Professor Peter Liljeström

  46. Low dose and gene gun immunization with a hepatitis C virus nonstructural (NS) 3 DNA-based vaccine containing NS4A inhibit NS3/4A-expressing tumors in vivo

    Article • Gene Therapy, April 2003, Springer Science + Business Media

    Professor Peter Liljeström

  47. Vaccination with Recombinant Alphavirus or Immune-Stimulating Complex Antigen Against Respiratory Syncytial Virus

    Article • The Journal of Immunology, September 2002, The American Association of Immunologists

    Professor Peter Liljeström, Associate Professor Margaret Chen

  48. Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols

    Article • The Journal of Immunology, May 2002, The American Association of Immunologists

    Dr Mariolina Salio, Professor Peter Liljeström

  49. Foreword

    Article • Vaccine, May 2002, Elsevier

    Professor Peter Liljeström

  50. Recombinant Semliki Forest virus vaccine vectors: the route of injection determines the localization of vector RNA and subsequent T cell response

    Article • Gene Therapy, September 2001, Springer Science + Business Media

    Professor Peter Liljeström

  51. A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model

    Article • Vaccine, July 2001, Elsevier

    Professor Peter Liljeström

  52. Comparative Immunization Study Using RNA and DNA Constructs Encoding a Part of the Plasmodium falciparum Antigen Pf332

    Article • Scandinavian Journal of Immunology, July 2001, Wiley

    Professor Peter Liljeström

  53. M-X-I Motif of Semliki Forest Virus Capsid Protein Affects Nucleocapsid Assembly

    Article • Journal of Virology, May 2001, ASM Journals

    Professor Peter Liljeström

  54. Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara

    Article • Vaccine, May 2001, Elsevier

    Professor Peter Liljeström, Professor Jonathan Luke Heeney

  55. Self‐Replicative RNA Vaccines Elicit Protection against Influenza A Virus, Respiratory Syncytial Virus, and a Tickborne Encephalitis Virus

    Article • The Journal of Infectious Diseases, May 2001, Oxford University Press (OUP)

    Professor Peter Liljeström

  56. Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems

    Article • Vaccine, February 2001, Elsevier

    Professor Peter Liljeström

  57. Use of Conventional or Replicating Nucleic Acid-Based Vaccines and Recombinant Semliki Forest Virus-Derived Particles for the Induction of Immune Responses Against Hepatitis C Virus Core and E2 Antigens

    Article • Virology, October 2000, Elsevier

    Professor Peter Liljeström

  58. A vaccine strategy utilizing a combination of three different chimeric vectors which share specific vaccine antigens

    Article • Journal of Medical Primatology, August 2000, Wiley

    Professor Peter Liljeström

  59. Alphavirus vectors: from protein production to gene therapy

    Article • Gene Therapy and Regulation, March 2000, Brill

    Professor Peter Liljeström

  60. Alphavirus Vectors: Highly Efficient Systems for Transient Gene Expression

    Article • January 2000, Springer Science + Business Media

    Professor Peter Liljeström

  61. Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene

    Article • Gene Therapy, October 1999, Springer Science + Business Media

    Professor Peter Liljeström

  62. An anti‐HIV strategy combining chemotherapy and therapeutic vaccination

    Article • Journal of Medical Primatology, August 1999, Wiley

    Professor Peter Liljeström

  63. Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

    Article • Vaccine, February 1999, Elsevier

    Professor Peter Liljeström

  64. Enhancing immune responses using suicidal DNA vaccines

    Article • Nature Biotechnology, June 1998, Springer Science + Business Media

    Professor Peter Liljeström

  65. Role of the C-terminal tryptophan residue for the structure-function of the alphavirus capsid protein

    Article • Journal of Molecular Biology, June 1998, Elsevier

    Professor Peter Liljeström

  66. Outcome of Immunization of Cynomolgus Monkeys with Recombinant Semliki Forest Virus Encoding Human Immunodeficiency Virus Type 1 Envelope Protein and Challenge with a High Dose of SHIV-4 Virus

    Article • AIDS Research and Human Retroviruses, November 1997, Mary Ann Liebert Inc

    Professor Peter Liljeström

  67. Cloning of human IL-12 p40 and p35 DNA into the Semliki Forest virus vector: expression of IL-12 in human tumor cells

    Article • Gene Therapy, April 1997, Springer Science + Business Media

    Professor Peter Liljeström

  68. Preface

    Article • Gene, January 1997, Elsevier

    Professor Peter Liljeström

  69. Alphavirus expression vectors and their use as recombinant vaccines: a minireview

    Article • Gene, January 1997, Elsevier

    Professor Peter Liljeström

  70. Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid

    Article • Structure, May 1996, Elsevier

    Professor Peter Liljeström

  71. Alphaviruses as vectors for gene delivery

    Article • Trends in Biotechnology, April 1996, Elsevier

    Professor Peter Liljeström

  72. Manipulation of the Semliki Forest virus genome and its potential for vaccine construction

    Article • Molecular Biotechnology, February 1996, Springer Science + Business Media

    Professor Peter Liljeström

  73. Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

    Article • Proceedings of the National Academy of Sciences, March 1995, Proceedings of the National Academy of Sciences

    Professor Peter Liljeström

  74. Recombinant Self-Replicating RNA Vaccines

    Article • January 1995, Springer Science + Business Media

    Professor Peter Liljeström

  75. High-Level Expression of G Protein-Coupled Receptors with the Aid of the Semliki Forest Virus Expression System

    Article • Journal of Receptors and Signal Transduction, January 1995, Taylor & Francis

    Professor Peter Liljeström

  76. The Tax transactivation protein of human T-cell leukemia virus type I colocalizes with NF-κB proteins in nuclear bodies

    Article • Journal of Cancer Research and Clinical Oncology, January 1995, Springer Science + Business Media

    Professor Peter Liljeström

  77. Self-replicating Semliki Forest virus RNA as recombinant vaccine

    Article • Vaccine, December 1994, Elsevier

    Professor Peter Liljeström

  78. Alphavirus expression systems

    Article • Current Opinion in Biotechnology, October 1994, Elsevier

    Professor Peter Liljeström

  79. High‐level Expression of the Human Neurokinin‐1 Receptor in Mammalian Cell Lines using the Semliki Forest Virus Expression System

    Article • European Journal of Biochemistry, September 1994, Wiley

    Professor Peter Liljeström

  80. A single amino acid change in the E2 spike protein of a virulent strain of Semliki Forest virus attenuates pathogenicity

    Article • Journal of General Virology, March 1994, Society for General Microbiology

    Professor Peter Liljeström

  81. Chapter 2 Expression of Exogenous Proteins in Mammalian Cells with the Semliki Forest Virus Vector

    Article • January 1994, Elsevier

    Professor Peter Liljeström

  82. Assembly and entry mechamisms of Semliki Forest virus

    Article • January 1994, Springer Science + Business Media

    Professor Peter Liljeström

  83. Plasminogen‐activator inhibitor type 2 (PAI‐2) is a spontaneously polymerising SERPIN

    Article • European Journal of Biochemistry, December 1993, Wiley

    Professor Peter Liljeström

  84. Expression of HIV-1 Envelope Glycoproteins by Semliki Forest Virus Vectors

    Article • AIDS Research and Human Retroviruses, October 1993, Mary Ann Liebert Inc

    Professor Peter Liljeström

  85. Semliki Forest Virus Expression System: Production of Conditionally Infectious Recombinant Particles

    Article • Nature Biotechnology, August 1993, Springer Science + Business Media

    Professor Peter Liljeström

  86. Overview: Virally Based Transient Expression Systems

    Article • Current Opinion on Therapeutic Patents, March 1993, Informa Healthcare

    Professor Peter Liljeström

  87. A New Generation of Animal Cell Expression Vectors Based on the Semliki Forest Virus Replicon

    Article • Biotechnology, December 1991, Springer Science + Business Media

    Professor Peter Liljeström

  88. Structure and expression of the ompB operon, the regulatory locus for the outer membrane porin regulon in Salmonella typhimurium LT-2

    Article • Journal of Molecular Biology, June 1988, Elsevier

    Professor Peter Liljeström

  89. Nucleotide sequence of the melA gene, Coding for α-galactosidase in Escherichia coli K-12

    Article • Nucleic Acids Research, January 1987, Oxford University Press (OUP)

    Professor Peter Liljeström

  90. The EnvZ protein of Salmonella typhimurium LT-2 and Escherichia coli K-12 is located in the cytoplasmic membrane

    Article • FEMS Microbiology Letters, September 1986, Oxford University Press (OUP)

    Professor Peter Liljeström

  91. In vivo transfer of chromosomal mutations onto multicopy plasmids by transduction with bacteriophage P1

    Article • Gene, January 1985, Elsevier

    Professor Peter Liljeström

  92. Live Viral Vectors: Semliki Forest Virus

    Article • Springer Science + Business Media

    Professor Peter Liljeström

  93. Delivery and Expression of Heterologous Genes in Mammalian Cells Using Self-Replicating Alphavirus Vectors

    Article • Springer Science + Business Media

    Professor Peter Liljeström

  94. The SFV Gene Expression System

    Article • Springer Science + Business Media

    Professor Peter Liljeström